N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction

• Published in: PloS one 2020-12, Vol.15 (12), p.e0243213
• Main Authors: Jones, Erika, Wei, Janet, Nelson, Michael D, Bakir, May, Mehta, Puja K, Shufelt, Chrisandra, Minissian, Margo, Sharif, Behzad, Pepine, Carl J, Handberg, Eileen, Cook-Wiens, Galen, Sopko, George, Bairey Merz, C. Noel
• Format: Article
• Language: English
• Subjects: Analysis; Demographic aspects; Diagnosis; Forecasts and trends; Health aspects; Heart failure; Myocardial ischemia; Natriuretic peptides; Risk factors; Women's health
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0243213

Women with symptoms and signs of ischemia, preserved left ventricular ejection fraction (LVEF), and no obstructive coronary artery disease (CAD), often have coronary microvascular dysfunction (CMD), and are at risk of future heart failure with preserved ejection fraction (HFpEF). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is used to evaluate HF and myocardial ischemia. Relationships between NT-proBNP and CMD are not well defined in this population. We evaluated resting NT-proBNP levels in 208 women with symptoms and signs of ischemic heart disease, preserved LVEF and no obstructive CAD undergoing clinically indicated invasive coronary flow reserve (CFR) as a measure of CMD-related ischemia and resting left ventricular end-diastolic pressure (LVEDP). Chi-square testing was used for categorical variables and ANOVA or Kruskal-Wallis tests were used for continuous variables. Overall, 79% had an elevated resting LVEDP, and mean NT-proBNP was 115 ± 158 pg/mL. NT-proBNP levels correlated directly with age (r = 0.28, p =